Editorial Director Allison Proffitt sat down with DrugDev Founder and President, Site Startup Liss Easy in February to discuss DrugDev’s new Site Activation technology and its promise of shaving weeks off the clinical trial startup process
Important Cookie Information – This message will only appear once.
DrugDev websites use cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies and their use, please see our Privacy Policy.
